Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

GABARAPL1 Activators

The chemical class known as GABARAPL1 Activatorsencompasses a diverse range of molecules that share the common feature of being able to induce the expression of the GABARAPL1 protein, a crucial component of the autophagy pathway. These activators are not unified by a single chemical structure or family; instead, they are categorized by their functional impact on GABARAPL1 expression levels. The mechanisms by which these chemicals operate are varied and often intersect with fundamental cellular signaling pathways and gene regulatory networks. Some activators function by inhibiting negative regulators of autophagy, such as mTOR, leading to an upregulation of autophagy-related genes, including GABARAPL1. Others may interact with the epigenetic machinery, modifying the transcriptional accessibility of genes associated with the autophagic process. This includes agents that affect histone acetylation and DNA methylation, thereby altering gene expression profiles in a manner that promotes the biogenesis of autophagy-related proteins.

Within the scope of cellular biology, GABARAPL1 Activators play significant roles in modulating the autophagy process, which is essential for cellular cleanup and turnover. By increasing the levels of GABARAPL1, these chemicals can enhance the autophagic flux, thereby contributing to the maintenance of cellular health and the balance of protein and organelle quality control. Research into GABARAPL1 Activators spans across molecular biology and biochemistry, highlighting the intricate balance of cellular processes these molecules can influence. These activators are often the subject of studies aiming to understand the regulation of autophagy at the molecular level, providing insights into how cells adapt to stress and maintain homeostasis. The activation of GABARAPL1 through these chemicals underscores the dynamic nature of intracellular pathways and the potential for modulation of core cellular functions. It's a field that continues to grow as new activators are identified and as our understanding of the autophagy pathway expands, revealing the sophisticated interplay between various signaling cascades and the autophagy machinery.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, which is a negative regulator of autophagy, thus potentially upregulating GABARAPL1 as part of the autophagy pathway.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Activates sirtuin 1, which is known to regulate autophagy and potentially enhances GABARAPL1 expression through a pathway involving deacetylation of autophagy-related proteins.

Spermidine

124-20-9sc-215900
sc-215900B
sc-215900A
1 g
25 g
5 g
$57.00
$607.00
$176.00
(2)

Induces autophagy through inhibition of acetyltransferase, which might upregulate GABARAPL1 as part of the broader autophagic response.

Metformin-d6, Hydrochloride

1185166-01-1sc-218701
sc-218701A
sc-218701B
1 mg
5 mg
10 mg
$292.00
$822.00
$1540.00
1
(1)

Activates AMPK, leading to inhibition of mTOR signaling and possible upregulation of autophagy pathways, including GABARAPL1 expression.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

HDAC inhibitor that may enhance gene expression including GABARAPL1 by altering chromatin structure.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

HDAC inhibitor that could upregulate GABARAPL1 through changes in chromatin accessibility.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methylation inhibitor that may upregulate genes including GABARAPL1 by preventing gene silencing.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-Azacytidine, it may increase GABARAPL1 expression by reducing methylation-based suppression.